Vir Biotechnology reports Q3 EPS ($1.56), consensus ($1.05)
PremiumThe FlyVir Biotechnology reports Q3 EPS ($1.56), consensus ($1.05)
9d ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
24d ago
Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments
Premium
Company Announcements
Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments
2M ago
Vir Biotechnology sees FY24 operating expense $580M-$610M
PremiumThe FlyVir Biotechnology sees FY24 operating expense $580M-$610M
3M ago
Vir Biotechnology reports Q2 EPS ($1.02), consensus (89c)
Premium
The Fly
Vir Biotechnology reports Q2 EPS ($1.02), consensus (89c)
3M ago
Vir Biotechnology trading halted, news pending
Premium
The Fly
Vir Biotechnology trading halted, news pending
3M ago
Vir Biotechnology combo shows ‘unprecedented’ response, says H.C. Wainwright
PremiumThe FlyVir Biotechnology combo shows ‘unprecedented’ response, says H.C. Wainwright
5M ago
Vir Biotechnology Anticipates Promising Hepatitis Trial Results
Premium
Company Announcements
Vir Biotechnology Anticipates Promising Hepatitis Trial Results
5M ago
Vir Biotechnology announces new preliminary data from SOLSTICE trial
Premium
The Fly
Vir Biotechnology announces new preliminary data from SOLSTICE trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100